Unibest
← Back to patent-cliff list

CAS 1557268-61-7

4-(3-aminophenoxy)-N-(3-fluoro-4-(4-methylpiperazin-1-yl)phenyl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine

Codes: AVITI-007

Application context (from source-drug indications)

Non-small cell lung cancerAbivertinibNon-Hodgkin lymphomaAbivertinibLymphomaAbivertinibChronic lymphocytic leukaemiaAbivertinibDiffuse large B-cell lymphomaAbivertinibMantle cell lymphomaAbivertinib

Source drugs (routes using this intermediate)

DrugTierExpiry
AbivertinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.